AbbVie Inc. (NYSE: ABBV) stock closed at 108.41 per share at the end of the most recent trading day (a 0.62% change compared to the prior day closing price) with a volume of 4.71M shares and market capitalization of 191.44B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 30000 people. AbbVie Inc. CEO is Richard A. Gonzalez.

The one-year performance of AbbVie Inc. stock is 26.62%, while year-to-date (YTD) performance is 1.18%. ABBV stock has a five-year performance of 94.63%. Its 52-week range is between 62.55 and 113.41, which gives ABBV stock a 52-week price range ratio of 90.17%

AbbVie Inc. currently has a PE ratio of 38.50, a price-to-book (PB) ratio of 14.55, a price-to-sale (PS) ratio of 4.18, a price to cashflow ratio of 10.20, a PEG ratio of 2.32, a ROA of 3.68%, a ROC of 14.01% and a ROE of 218.05%. The company’s profit margin is 10.22%, its EBITDA margin is 26.90%, and its revenue ttm is $45.80 Billion , which makes it $25.94 revenue per share.

Of the last four earnings reports from AbbVie Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $2.85 for the next earnings report. AbbVie Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for AbbVie Inc. is Moderate Buy (1.64), with a target price of $116.73, which is +7.67% compared to the current price. The earnings rating for AbbVie Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

AbbVie Inc. has a dividend yield of 4.80% with a dividend per share of $5.20 and a payout ratio of 98.00%.

AbbVie Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 7.84, ATR14 : 3.28, CCI20 : 67.86, Chaikin Money Flow : -0.05, MACD : 0.19, Money Flow Index : 53.74, ROC : 3.55, RSI : 54.49, STOCH (14,3) : 72.97, STOCH RSI : 0.68, UO : 52.36, Williams %R : -27.03), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of AbbVie Inc. in the last 12-months were: Azita Saleki-Gerhardt (Option Excercise at a value of $116 199), Azita Saleki-Gerhardt (Sold 22 226 shares of value $2 157 076 ), Brian L. Durkin (Buy at a value of $362 705), Carlos Alban (Option Excercise at a value of $4 155 980), Carlos Alban (Sold 169 155 shares of value $16 915 554 ), Edward J. Rapp (Buy at a value of $505 234), Elaine K. Sorg (Option Excercise at a value of $1 813 052), Elaine K. Sorg (Sold 20 195 shares of value $2 114 732 ), Henry O. Gosebruch (Sold 40 000 shares of value $3 975 046 ), Jeffrey Ryan Stewart (Option Excercise at a value of $2 600 822), Jeffrey Ryan Stewart (Sold 96 628 shares of value $9 455 320 ), Michael Severino (Sold 90 679 shares of value $8 488 461 ), Richard A. Gonzalez (Option Excercise at a value of $11 089 858), Richard A. Gonzalez (Sold 231 604 shares of value $22 437 252 ), Timothy J. Richmond (Option Excercise at a value of $2 673 325), Timothy J. Richmond (Sold 71 435 shares of value $7 111 775 )